Ayala Pharmaceuticals Inc (AYLA) is a publicly traded biotechnology business based in the US. On 22 September Ayala Pharmaceuticals Inc shares plunged 13.99% to a closing position of $0.9461. Over the last 12 months, Ayala Pharmaceuticals Inc's share price has fallen by 28.56% from $11.52. Ayala Pharmaceuticals Inc is listed on the NASDAQ and employs 35 staff. All prices are listed in US Dollars.
Best for
0% commission
Best for
Beginner investments
Best for
Mobile app
Best for
Index funds
Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.
| Platform | Platform fee | Min. initial deposit | Trading fee estimate | |
|---|---|---|---|---|
|
£0 | $10 | £3.63 £730.09 total |
Capital at risk |
|
£0 | £250 | £12.50 £738.97 total |
Capital at risk |
|
£0 | No minimum | £7.26 £733.73 total |
Capital at risk |
 |
£0 | £1 | £19.21 £745.68 total |
Capital at risk |
 |
£0 | £0.01 | £0.73 £727.19 total |
Capital at risk |
 |
£9.99 per month | No minimum | £18.89 £745.35 total |
Capital at risk |
 |
£0 | £50 | £3.63 £730.09 total |
Capital at risk |
 |
£36 per year | £20 | £18.58 £745.04 total |
Capital at risk |
Full comparison of share dealing platforms
Historical closes compared with the last close of $8.23
| 1 week (2022-09-28) | 731.31% |
|---|---|
| 1 month (2022-09-02) | 317.77% |
| 3 months (2022-07-05) | 654.98% |
| 6 months (2022-04-05) | 108.88% |
| 1 year (2021-10-05) | -28.56% |
|---|---|
| 2 years (2020-10-05) | -33.31% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
| Open | $8.11 |
|---|---|
| High | $9.09 |
| Low | $8.07 |
| Close | $8.23 |
| Previous close | $8.13 |
| Change | $0.1 |
| Change % | 1.23% |
| Volume | 88,355 |
| 52-week range | $0.7 - $14.5 |
|---|---|
| 50-day moving average | $1.4269 |
| 200-day moving average | $3.2737 |
| Wall St. target price | $11.29 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.714 |
We're not expecting Ayala Pharmaceuticals Inc to pay a dividend over the next 12 months. Typically it's companies that have been around for longer that pay dividends (Ayala Pharmaceuticals Inc had its IPO on 8 May 2020). However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Ayala Pharmaceuticals Inc's shares have ranged in value from as little as $0.7 up to $14.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ayala Pharmaceuticals Inc's is 2.2597. This would suggest that Ayala Pharmaceuticals Inc's shares are significantly more volatile than the average for this exchange and represent a higher risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Everything we know about the Porsche IPO, plus information on how to buy shares.
Our Minuts review looks at the features, customer reviews, fees, learning resources and some pros and cons of investing with Mintus
Thinking about buying shares in Flex LNG? We explain how to do it and compare a range of providers who will give you access to global markets.
Everything we know about the Corebridge Financial IPO, plus information on how to buy shares.
GreenGrowth is a brand new ethical investment platform that creates a portfolio for you based on your carbon footprint. See what we thought.
Investing in art could be a nice way to animate your investment portfolio with an alternative asset. Here’s how it works and the risks.
We explain the different account types that you’ll come across when signing up with an investment platform.
Everything we know about the Hempacco IPO, plus information on how to buy shares.
Everything we know about the Jianzhi Education Technology Group IPO, plus information on how to buy shares.
Find out the best time to invest in stocks, the risks involved, plus a range of different strategies to consider when investing.
